Differential decline in Leishmania membrane antigen-specific immunoglobulin G (IgG), IgM, IgE, and IgG subclass antibodies in Indian Kala- Azar patients after chemotherapy

Infection and Immunity

Volumn 67, Issue 12, 1999, Pages 6663-6669

  Anam, Khairul ^a   Afrin, Farhat ^a   Banerjee, Dwijadas ^b   Pramanik, Netai ^b   Guha, Subhasis K ^b   Goswami, Rama P ^b   Saha, Shiben K ^b   Ali, Nahid ^a  

^a INDIAN INSTITUTE OF CHEMICAL BIOLOGY   (India)

^b CALCUTTA SCHOOL OF TROPICAL MEDICINE   (India)

Author keywords

[No Author keywords available]

Indexed keywords

IMMUNOGLOBULIN A; IMMUNOGLOBULIN E; IMMUNOGLOBULIN G; IMMUNOGLOBULIN M; STIBOGLUCONATE SODIUM;

ADOLESCENT; ADULT; AGED; ARTICLE; CELL PROLIFERATION; CELLULAR IMMUNITY; CHILD; CLINICAL ARTICLE; FEMALE; HUMAN; IMMUNE RESPONSE; IMMUNOGLOBULIN BLOOD LEVEL; INFECTION RISK; LEISHMANIA DONOVANI; LEISHMANIASIS; MALE; PRIORITY JOURNAL;

ADOLESCENT; ADULT; AGED; AMPHOTERICIN B; ANIMALS; ANTIBODIES, PROTOZOAN; ANTIBODY SPECIFICITY; ANTIGENS, PROTOZOAN; ANTIMONY SODIUM GLUCONATE; ANTIPROTOZOAL AGENTS; CHILD; CHILD, PRESCHOOL; DRUG RESISTANCE; FEMALE; HUMANS; IMMUNOBLOTTING; IMMUNOGLOBULIN ISOTYPES; LEISHMANIA DONOVANI; LEISHMANIASIS, VISCERAL; MALE; MIDDLE AGED;

EID: 0032749833     PISSN: 00199567     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (48)

1. Abbas, A. K., K. M. Murphy, and A. Sher. 1996. Functional diversity of helper T lymphocytes. Nature 383:787-793.
2. Afrin, F., and N. Ali. 1997. Adjuvanticity and protective immunity elicited by Leishmania donovani antigen encapsulated in positively charged liposomes. Infect. Immun. 65:2371-2377.
3. Afrin, F., and N. Ali. 1998. Isotype profiles of Leishmania donovani infected BALB/c mice: preferential stimulation of IgG2a/b by liposome associated promastigote antigens. J. Parasitol. 84:743-748.
4. Ali, N., and F. Afrin. 1997. Protection of mice against visceral leishmaniasis by immunization with promastigote antigen incorporated in liposome. J. Parasitol. 83:70-75.
5. Anam, K., F. Afrin, D. Banerjee, N. Pramanik, S. K. Guha, R. P. Goswami, P. N. Gupta, S. K. Saha, and N. Ali. 1999. Immunoglobulin subclass distribution and diagnostic value of Leishmania donovani antigen-specific immunoglobulin G3 in Indian kala-azar patients. Clin. Diagn. Lab. Immunol. 6:231-235.
6. Badaro, R., D. Benson, M. C. Eulalio, M. Freire, S. Cunha, E. M. Netto, D. Predral-Sampaio, C. Madurcira, J. M. Burns, R. L. Houghton, J. R. David, and S. G. Reed. 1996. rK39: a clonal antigen of Leishmania chagasi that predicts active visceral leishmaniasis. J. Infect. Dis. 173:758-761.
7. Bahrenscheer, J., M. Kemp, J. A. L. Kurtzhals, G. S. Gachihi, A. Kharazmi, and T. G. Theander. 1995. Interferon-γ and interleukin-4 production by human T cells recognizing Leishmania donovani antigens separated by SDS-PAGE. APMIS 103:131-139.
8. Batteiger, B., W. J. V. Newhall, and R. B. Jones. 1982. The use of Tween 20 as blocking agent in the immunological detection of proteins transferred to nitrocellulose membranes. J. Immunol. Methods 55:297-307.
9. Bouvier, J., R. Etges, and C. Bordier. 1987. Identification of promastigote surface protease in seven species of Leishmania. Mol. Biochem. Parasitol. 24:73-79.
10. Bray, R. S. 1976. Immunodiagnosis of leishmaniasis, p. 65-76. In S. Cohen and E. H. Sadun (ed.), Immunology of parasite infections. Blackwell Scientific Publications, Oxford, United Kingdom.
11. Bretscher, P. A., G. Wei, J. N. Menon, and H. Bielefeldt-Ohmann. 1992. Establishment of stable, cell-mediated immunity makes "susceptible" mice resistant to Leishmania major. Science 257:539-542.
12. Burns, J. M., Jr., W. G. Shreffler, D. R. Benson, H. W. Ghalib, R. Badaro, and S. G. Reed. 1993. Molecular characterization of a kinensin-related antigen of Leishmania chagasi that detects specific antibody in African and American visceral leishmaniasis. Proc. Natl. Acad. Sci. USA 90:775-779.
13. Carvalho, E. M., R. Badaro, S. G. Reed, T. C. Jones, and W. D. Johnson. 1985. Absence of gamma interferon and interleukin 2 production during visceral leishmaniasis. J. Clin. Investig. 76:2066-2069.
14. Champsi, J., and D. McMahon-Pratt. 1988. Membrane glycoprotein M-2 protects against Leishmania amazonensis infection. Infect. Immun. 56:3272-3279.
15. Cillari, E., F. Y. Liew, P. L. Campo, S. Milano, S. Mansueto, and A. Salerno. 1988. Suppression of IL-2 production by cryopreserved peripheral blood mononuclear cells from patients with active visceral leishmaniasis in Sicily. J. Immunol. 140:2721-2726.
16. Coffman, R. L., D. A. Lebman, and P. Rothman. 1993. The mechanism and regulation of immunoglobulin isotype switching. Adv. Immunol. 54:229-270.
17. Desjeux, P. 1992. Human leishmaniasis: epidemiology and public health aspects. World Health Stat. Q. 45:267-275.
18. Elassad, A. M. S., S. A. Younis, M. Siddig, J. Grayson, E. Petersen, and H. W. Ghalib. 1994. The significance of blood levels of IgM, IgA, IgG and IgG subclasses in Sudanese visceral leishmaniasis patients. Clin. Exp. Immunol. 95:294-299.
19. Fargeas, C., M. Hommel, R. Maingon, C. Dourado, M. Monsigny, and R. Mayer. 1996. Synthetic peptide-based enzyme-linked immunosorbent assay for serodiagnosis of visceral leishmaniasis. J. Clin. Microbiol. 34:241-248.
20. Ghalib, H. W., M. R. Piuvezam, Y. A. W. Skeiky, M. Siddig, F. A. Hashim, A. M. El-Hassan, D. M. Russo, and S. G. Reed. 1993. Interleukin 10 production correlates with pathology in human Leishmania donovani infections. J. Clin. Investig. 92:324-329.
21. Ghosh, A. K., S. Dasgupta, and A. C. Ghose. 1995. Immunoglobulin G subclass-specific antileishmanial antibody responses in Indian kala-azar and post kala-azar dermal leishmaniasis. Clin. Diagn. Lab. Immunol. 2:291-296.
22. Hailu, A. 1990. Pre- and post-treatment antibody levels in visceral leishmaniasis. Trans. R. Soc. Trop. Med. Hyg. 84:673-675.
23. Jaffe, C. L., and M. Zalis. 1988. Purification of two Leishmania donovani membrane antigens recognized by sera from patients with visceral leishmaniasis. Mol. Biochem. Parasitol. 27:53-62.
24. Jefferis, R. 1990. Structure/function relationships of IgG subclasses, p. 93-108. In F. Shakib (ed.). The human IgG subclasses: molecular analysis of structure, function and regulation. Pergamon Press, London, United Kingdom.
25. Jha, T. K., P. Olliaro, C. P. N. Thakur, T. P. Kanyok, B. L. Singhania, I. J. Singh, N. K. P. Singh, S. Akhoury, and S. Jha. 1998. Randomised controlled trial of aminosidine (paromomycin) v sodium stibogluconate for treating visceral leishmaniasis in North Bihar, India. Br. Med. J. 316:1200-1205.
26. Karp, C. L., S. H. El-Safi, T. A. Wynn, M. M. H. Satti, A. M. Kordofani, F. A. Hashim, M. Hag-Ali, F. A. Neva, T. B. Nutman, and D. L. Sacks. 1993. In vivo cytokine profiles in patients with kala-azar. Marked elevation of both interleukin 10 and interferon-gamma. J. Clin. Investig. 91:1644-1648.
27. Kemp, M., J. A. L. Kurtzhals, K. Bendtzen, L. K. Poulsen, M. B. Hansen, D. K. Koech, A. Kharazmi, and T. G. Theander. 1993. Leishmania donovani-reactive Th1- and Th2-like T-cell clones from individuals who have recovered from visceral leishmaniasis. Infect. Immun. 61:1069-1073.
28. Kenny, R. T., D. L. Sacks, A. A. Gam, H. W. Murray, and S. Sundar. 1998. Splenic cytokine responses in Indian kala-azar before and after treatment. J. Infect. Dis. 177:815-819.
29. Kurtzhals, J. A. L., A. S. Hey, T. G. Theander, E. Odera, C. B. V. Christensen, J. I. Githure, D. K. Koech, K. U. Schaefer, E. Handman, and A. Kharazmi. 1992. Cellular and humoral immune responses in a population from the Baringo District, Kenya, to Leishmania promastigote lipophosphoglycan. Am. J. Trop. Med. Hyg. 46:480-488.
30. Kutner, S., P. Pellerin, S. F. Breniere, P. Desjeux, and J. P. Dedet. 1991. Antigenic specificity of the 72-kilodalton major surface glycoprotein of Leishmania braziliensis braziliensis. J. Clin. Microbiol. 29:595-599.
31. Lowry, O. H., N. J. Rosebrough, A. L. Fair, and R. J. Randall. 1951. Protein measurement with the Folin phenol reagent. J. Biol. Chem. 193:265-275.
32. Marty, P., A. Lelievre, J.-F. Quaranta, I. Suffia, M. Eulalio, M. Gari-Toussaint, Y. Le Fichoux, and J. Kubar. 1995. Detection by western blot of four antigens characterizing acute clinical leishmaniasis due to Leishmania infantum. Trans. R. Soc. Trop. Med. Hyg. 89:690-691.
33. Mary, C., D. Lamouroux, S. Dunan, and M. Quilici. 1992. Western blot analysis of antibodies to Leishmania infantum antigens: potential of the 14-kD and 16-kD antigens for diagnosis and epidemiologic purposes. Am. J. Trop. Med. Hyg. 47:754-771.
34. Neogy, A. B., A. Nandy, B. G. Dastidar, and A. B. Chowdhury. 1987. Antibody kinetics in kala-azar in response to treatment. Ann. Trop. Med. Parasitol. 81:727-729.
35. Pal, A., K. Mukerji, D. Basu, K. Naskar, K. K. Mullick, and D. K. Ghosh. 1991. Evaluation of direct agglutination test (DAT) and ELISA for serodiagnosis of visceral leishmaniasis in India. J. Clin. Lab, Anal. 5:303-306.
36. Qu, J.-Q., L. Zhong, M. Masoom-Yasinzai, M. Abdur-Rab, H. S. Z. Aksu, S. G. Reed, K.-P. Chang, and A. Gilman-Sachs. 1994. Serodiagnosis of Asian leishmaniasis with a recombinant antigen from the repetitive domain of a Leishmania kinensin. Trans. R. Soc. Trop. Med. Hyg. 88:543-545.
37. Rezai, H. R., S. M. Ardehali, G. Amirhakimi, and A. Kharazami. 1978 Immunological features of kala-azar. Am. J. Trop. Med. Hyg. 27:1079-1083.
38. Rolland-Burger, L., X. Rolland, C. W. Grieve, and L. Monjour. 1991. Immunoblot analysis of the humoral immune response to Leishmania donovani infantum polypeptides in human visceral leishmaniasis. J. Clin. Microbiol. 29:1429-1435.
39. Rothman, P., and R. L. Coffman. 1996. Immunoglobulin heavy chain class-switching, p. 19.1-19.14. In L. A. Herzenberg (ed.). Weir's handbook of experimental immunology, 5th ed. Blackwell Scientific Publications, Oxford, United Kingdom.
40. Sacks, D. L., S. L. Lal, S. N. Shrivastava, J. Blackwell, and F. A. Neva. 1987, An analysis of T cell responsiveness in Indian kala-azar. J. Immunol. 138: 908-913.
41. Shiddo, S. A., G. Huldt, L.-A. Nilsson, O. Ouchterlony, and R. Thorstensson. 1996. Visceral leishmaniasis in Somalia. Significance of IgG subclasses and of IgE response. Immunol. Lett. 50:87-93.
42. Shreffler, W. G., J. M. Burns, Jr., R. Badaro, H. W. Ghalib, L. L. Button, W. R. McMaster, and S. G. Reed. 1993. Antibody responses of visceral leishmaniasis patients to gp63, a major surface glycoprotein of Leishmania species. J. Infect. Dis. 167:426-430.
43. Singh, S., A. Gilman-Sachs, K.-P. Chang, and S. G. Reed. 1995. Diagnostic and prognostic value of k39 recombinant antigen in Indian leishmaniasis. J. Parasitol. 81:1000-1003.
44. Skeiky, Y. A. W., D. R. Benson, J. L. M. Costa, R. Badaro, and S. G. Reed. 1997. Association of Leishmania heat shock protein 83 antigen and immunoglobulin G4 antibody titers in Brazilian patients with diffuse cutaneous leishmaniasis. Infect. Immun. 65:5368-5370.
45. Snapper, C. M., and W. E. Paul. 1987. Interferon γ and B cell stimulatory factor-1 reciprocally regulate Ig isotype production. Science 236:944-947.
46. Sundar, S., S. G. Reed, S. Sharma, A. Mehrotra, and H. W. Murray. 1997. Circulating T helper 1 (Th1) cell- and Th2 cell-associated cytokines in Indian patients with visceral leishmaniasis. Am. J. Trop. Med. Hyg. 56:522-525.
47. Ulrich, M., V. Rodriguez, M. Centeno, and J. Convit. 1995. Differing antibody IgG isotypes in the polar forms of leprosy and cutaneous leishmaniasis characterized by antigen-specific T cell anergy. Clin. Exp. Immunol. 100:54-58.
48. Zwingenberger, K., G. Harms, C. Pedrosa, S. Omena, B. Sandkamp, and S. K. Neifer. 1990. Determinants of the immune response in visceral leishmaniasis. Evidence for the predominance of endogenous interleukin 4 over interferon gamma production. Clin. Immunol. Immunopathol. 57:242-249.